Details for Patent: 12,653,820
Which drugs does patent 12,653,820 protect, and when does it expire?
Patent 12,653,820 protects HYDROMORPHONE HYDROCHLORIDE and is included in one NDA.
This patent has three patent family members in three countries.
Summary for Patent: 12,653,820
| Title: | Hydromorphone formulations for multi-dose products |
| Abstract: | The present disclosure relates to a multi-dose vial presentation for hydromorphone. In particular, the present disclosure relates to terminally sterilized liquid formulations comprising hydromorphone hydrochloride packaged in a multi-dose glass vial. The present disclosure also relates to methods of treating patients by administration of such formulations and glass vials containing such formulations. |
| Inventor(s): | Nathan Puster, Rand H. Ahmad, Gyongyi Szakalas-Gratzl, Ragheb M. AbuRmaileh |
| Assignee: | Hikma Pharmaceuticals USA Inc |
| Application Number: | US18/152,303 |
|
Patent Claim Types: see list of patent claims | Use; Formulation; |
Drugs Protected by US Patent 12,653,820
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma | HYDROMORPHONE HYDROCHLORIDE | hydromorphone hydrochloride | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 217812-001 | Dec 14, 2023 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | USE OF HYDROMORPHONE HYDROCHLORIDE FOR THE MANAGEMENT OF PAIN SEVERE ENOUGH TO REQUIRE AN OPIOID ANALGESIC AND FOR WHICH ALTERNATIVE TREATMENTS ARE INADEQUATE | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,653,820
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 4648774 | ⤷ Start Trial | |||
| Jordan | P20250163 | ⤷ Start Trial | |||
| World Intellectual Property Organization (WIPO) | 2024151603 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
